Biolase Technology (BIOL) 2.24 $BIOL
Company calls BIOLASE Website Representations False and Misleading
Marketwire - Mon Mar 24, 12:53PM CDT
Millennium Dental Technologies Inc. (MDT) -- the world leader in dentist satisfaction of its signature value propositions LANAP(R) and LAPIP(TM) protocols -- has issued comments regarding false and misleading representations made by Biolase Inc. regarding a former MDT management level employee. The company considers the statements made by Biolase regarding MDT former vice president of global sales and marketing, Brian Jaffe, to be false and misleading.
BIOLASE announces formation of four member board
M2 - Mon Mar 24, 5:15AM CDT
Biomedical company BIOLASE (NASDAQ:BIOL) disclosed on Friday that the Chancery Court of Delaware has announced a status quo order to establish a board of directors.
Concise Analysis of the International Dental Diagnostic and Surgical Equipment Market
M2 - Mon Mar 24, 5:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q52vzz/global_dental) has announced the addition of the "Concise Analysis of the International Dental Diagnostic and Surgical Equipment Market" report to their offering. The adoption of 3D cone-beam dental imaging in general dentistry, coupled with innovative implant procedures, oral surgery, temporo-mandibular joint analysis, and periodontal and orthodontic procedures, is an emerging trend that is expected to positively impact the Global Dental Diagnostic and Surgical Equipment market. Such innovative procedures make it possible to look at a tooth from any direction or orientation and in 3D, which eliminates much of the guesswork commonly experienced with 2D radiographs. The technique allows views of critical anatomy such as bone structure and tooth orientation to be captured. It aids in the accurate planning of procedures such as implants and oral surgery for more predictable outcomes, in addition to reducing treatment time and radiation. According to the report, one of the main drivers of this market is the increasing elderly population and the associated dental problems such as root caries, periodontal disease, missing teeth, edentulism, poor quality of alveolar ridges, various types of oral cancers, and caries. An increase in the edentulous population is also increasing demand for dental imaging and surgeries. Further, the report states that the market is experiencing challenges such as a lack of awareness of the risk of oral cancer, especially in developing countries such as Singapore, China, Brazil, and India. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Scope of the Report 4. Market Research Methodology 5. Introduction 6. Market Landscape 7. Market Segmentation by Product 8. Geographical Segmentation 9. Key Leading Countries 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor Analysis 19. Other Reports in this Series Companies Mentioned: - 3M Healthcare Ltd. - A-dec Inc. - Aribex Inc. - BIOLASE Inc. - Carestream Health Inc. - Danaher Corp. - Dental Equipment LLC and GC Corp. - Planmeca Oy. - Sirona Dental Systems Inc. For more information visit http://www.researchandmarkets.com/research/q5...bal_dental
Court Sets BIOLASE Board at Four Members
Marketwire - Fri Mar 21, 2:05PM CDT
BIOLASE, Inc. (NASDAQ: BIOL) announced that on March 20, 2014, the Chancery Court of Delaware entered a status quo order establishing a Board of Directors consisting of Federico Pignatelli, Chief Executive Officer and Chairman, Frederic H. Moll, Norman J. Nemoy and James R. Talevich (the "Board"
pending outcome of the litigation filed by Oracle on March 11, 2014. During the status quo period, any Board decision requires approval of at least three of four of these directors and, in certain cases, 10 day notice prior to the decision.
Concise Analysis of the International Energy Based Medical Devices Market
M2 - Fri Mar 14, 4:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/23fbb3/energy_based) has announced the addition of the "Concise Analysis of the International Energy Based Medical Devices Market" report to their offering. This report analyzes the worldwide markets for Energy Based Medical Devices in US$ Million by the following product segments: - Cryotherapy - Electrical - Radiation - Radiofrequency - Ultrasound - Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 145 companies including many key and niche players such as: - AngioDynamics, Inc. - ArthroCare Corporation - AtriCure, Inc. - BIOLASE, Inc. - biolitec AG - Biomet, Inc. - Covidien plc Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends, Issues & Drivers 3. Product Overview 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 145 (including Divisions/Subsidiaries - 180) - The United States (76) - Canada (4) - Japan (15) - Europe (54) - France (4) - Germany (20) - The United Kingdom (6) - Italy (6) - Spain (4) - Rest of Europe (14) - Asia-Pacific (Excluding Japan) (21) - Latin America (2) - Middle East (
For more information visit http://www.researchandmarkets.com/research/23...ergy_based About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
BIOLASE Comments on Oracle Partners L.P. Press Release
Marketwire - Thu Mar 13, 1:10PM CDT
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today issued a statement in response to a press release issued by Oracle Partners L.P. ("Oracle" announcing its nomination of four director candidates to stand for election to the BIOLASE(R) Board of Directors at the Company's 2014 Annual Meeting of Stockholders. BIOLASE shareholders are not required to take any action at this time.
Oracle Partners Commences Legal Action Against Biolase, Inc.
PR Newswire - Wed Mar 12, 2:19PM CDT
Oracle Partners, L.P. ("Oracle" , Biolase, Inc.'s ("Biolase" or the "Company" (Nasdaq: BIOL) largest shareholder, announced that it has commenced legal action in the Delaware Court of Chancery against the Company seeking to enjoin action in violation of the Company's Bylaws and Delaware law. The unlawful action occurred when the Company, without approval of the Board, purportedly expanded the Company's Board of Directors from six to eight directors and reappointed two directors who had previously resigned from the Board. Specifically:
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
PR Newswire - Tue Mar 11, 12:30PM CDT
Oracle Partners, L.P. ("Oracle" , Biolase, Inc.'s ("Biolase" or the "Company" (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board, citing management and Board entrenchment in the face of continuing poor financial performance.
BIOLASE Reports 2013 Fourth Quarter, Year End Results
Marketwire - Wed Mar 05, 3:05PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today reported unaudited financial results for the fourth quarter and year ended December 31, 2013.
BIOLASE CEO to Continue at Symbolic Annual Cash Salary of $1.00
Marketwire - Wed Mar 05, 3:02PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, announced today that Chairman and Chief Executive Officer Federico Pignatelli will continue at a symbolic annual cash salary of $1.00 for the year ending December 31, 2014.
BIOLASE Declares Stock Dividend for 2014 First Quarter
Marketwire - Wed Mar 05, 3:00PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that its Board of Directors (the "Board" has declared a one-half percent stock dividend payable on March 28, 2014, to stockholders of record on March 14, 2014. In addition, the Board adopted a two percent annual stock dividend policy for 2014.
5 Hated Earnings Stocks You Should Love
at The Street - Tue Mar 04, 11:57AM CST
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
BIOLASE Adds Two New Independent Directors to Its Board
Marketwire - Mon Mar 03, 8:02AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that the Board of Directors (the "Board" has appointed Paul Clark and Jeffrey Nugent to the Board. Dr. Alexander K. Arrow and Dr. Sam Low tendered their resignations from the Board on February 28, 2013. As a result of these appointments and resignations, BIOLASE's Board currently consists of six directors, five of whom are independent directors.
BIOLASE(R) to Host Fourth Quarter Financial Results Conference Call on March 5, 2014
Marketwire - Wed Feb 26, 8:02AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that the Company will host a conference call on Wednesday, March 5th, at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and year ended December 31, 2013, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Standard Time that same day.
BIOLASE(R) Completes First Phase of Cost Saving Measures
Marketwire - Tue Feb 25, 8:04AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that it has recently embarked on an in-depth cost saving program for fiscal 2014.
BIOLASE(R) Reaches the Mark of 25,000 Lasers Sold in Dentistry
Marketwire - Mon Feb 24, 8:03AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and GalaxyBioMill(TM) CAD/CAM systems for dentistry, today announced that it sold its 25,000th laser into the dental market last week.
BIOLASE(R) Files False Advertising Lawsuit Against Competitors
Marketwire - Fri Feb 21, 8:00AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and GalaxyBioMill(TM) CAD/CAM systems for dentistry, today announced that it filed a lawsuit in the United States District Court for the Central District of California against Fotona d.d. and Technology4Medicine L.L.C., two of its competitors (together "the Defendants" . The lawsuit alleges six causes of action, and claims that the Defendants have made false and misleading statements regarding BIOLASE's products, technology, and management. The lawsuit, filed on February 20, 2014, seeks both cash damages and injunctive relief.
Concise Analysis of the International Dental Equipment Market - Forecast to 2018
M2 - Fri Feb 21, 4:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/7s4r2f/dental_equipment) has announced the addition of the "Concise Analysis of the International Dental Equipment Market - Forecast to 2018" report to their offering. Dental Equipment and imaging devices find application in a dental office for diagnosis and treatment of various dental ailments such as caries and gingival disease. This report estimates the market of the global dental equipment market in terms of revenue (USD million) for the period 2012 - 2018, keeping 2011 as the base year. The global dental equipment market is segmented into two categories viz. market by products and market by geography. The global market by product types is further classified into six categories namely dental radiology equipment, dental lasers, systems and parts, laboratory machines, hygiene maintenance devices and other equipment. Dental radiology equipment consists of two sub-types i.e. intra-oral equipment and extra-oral equipment. The dental laser market on is further segregated the basis of technology into three types viz. diode lasers, carbon dioxide lasers and yttrium aluminum garnet lasers. Systems and parts are enumerated as instrument delivery systems, vacuums and compressors, cone beam CT systems, cast machines, furnace and ovens, electrosurgical equipment, CAD/CAM and others. The various laboratory machines described in the report are ceramic furnaces, hydraulic press, electronic waxer, suction units and micro motors. The hygiene maintenance devices include sterilizers, air purification & filters and hypodermic needle incinerators. Other equipments described in the report are dental chairs, hand piece, light cure and scaling units. The global dental equipment market is also segmented on the basis of geography into North America, Europe, Asia and Rest of the World (RoW) regions. Key Topics Covered: 1 Key Findings 2 Preface 3 Global Dental Equipment Market - Industry Analysis 4 Global Dental Equipment Market, By Products 5 Global Dental Equipment Market, By Geography 6 Company Profiles Companies Mentioned: - 3M ESPE - A- Dec Inc, - Biolase Inc. - Carestream Heath, Inc. - Danaher Corporation - Dentsply International Inc. - GC Corporation - Henry Schein, Inc. - Hu- Friedy Mgf Co. - Ivoclar Vivadent AG - Midmark Corporation - Patterson Companies Inc. - Planmecaoy - Sirona Dental Systems Inc. - Noble Biocare - Straumann For more information visit http://www.researchandmarkets.com/research/7s..._equipment
Stratasys Appoints BIOLASE(R) as a Distributor of Its Design Series 3-D Printers
Marketwire - Thu Feb 20, 8:03AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and GalaxyBioMill(TM) CAD/CAM systems for dentistry, today announced that it has entered into a Reseller Agreement (the "Agreement" with Stratasys, Inc. (NASDAQ: SSYS).
5 Stocks Insiders Love Right Now
at The Street - Wed Feb 19, 11:49AM CST
Insiders at these companies have been scooping up shares of their own stock lately.
Company calls BIOLASE Website Representations False and Misleading
Marketwire - Mon Mar 24, 12:53PM CDT
Millennium Dental Technologies Inc. (MDT) -- the world leader in dentist satisfaction of its signature value propositions LANAP(R) and LAPIP(TM) protocols -- has issued comments regarding false and misleading representations made by Biolase Inc. regarding a former MDT management level employee. The company considers the statements made by Biolase regarding MDT former vice president of global sales and marketing, Brian Jaffe, to be false and misleading.
BIOLASE announces formation of four member board
M2 - Mon Mar 24, 5:15AM CDT
Biomedical company BIOLASE (NASDAQ:BIOL) disclosed on Friday that the Chancery Court of Delaware has announced a status quo order to establish a board of directors.
Concise Analysis of the International Dental Diagnostic and Surgical Equipment Market
M2 - Mon Mar 24, 5:08AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q52vzz/global_dental) has announced the addition of the "Concise Analysis of the International Dental Diagnostic and Surgical Equipment Market" report to their offering. The adoption of 3D cone-beam dental imaging in general dentistry, coupled with innovative implant procedures, oral surgery, temporo-mandibular joint analysis, and periodontal and orthodontic procedures, is an emerging trend that is expected to positively impact the Global Dental Diagnostic and Surgical Equipment market. Such innovative procedures make it possible to look at a tooth from any direction or orientation and in 3D, which eliminates much of the guesswork commonly experienced with 2D radiographs. The technique allows views of critical anatomy such as bone structure and tooth orientation to be captured. It aids in the accurate planning of procedures such as implants and oral surgery for more predictable outcomes, in addition to reducing treatment time and radiation. According to the report, one of the main drivers of this market is the increasing elderly population and the associated dental problems such as root caries, periodontal disease, missing teeth, edentulism, poor quality of alveolar ridges, various types of oral cancers, and caries. An increase in the edentulous population is also increasing demand for dental imaging and surgeries. Further, the report states that the market is experiencing challenges such as a lack of awareness of the risk of oral cancer, especially in developing countries such as Singapore, China, Brazil, and India. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Scope of the Report 4. Market Research Methodology 5. Introduction 6. Market Landscape 7. Market Segmentation by Product 8. Geographical Segmentation 9. Key Leading Countries 10. Buying Criteria 11. Market Growth Drivers 12. Drivers and their Impact 13. Market Challenges 14. Impact of Drivers and Challenges 15. Market Trends 16. Trends and their Impact 17. Vendor Landscape 18. Key Vendor Analysis 19. Other Reports in this Series Companies Mentioned: - 3M Healthcare Ltd. - A-dec Inc. - Aribex Inc. - BIOLASE Inc. - Carestream Health Inc. - Danaher Corp. - Dental Equipment LLC and GC Corp. - Planmeca Oy. - Sirona Dental Systems Inc. For more information visit http://www.researchandmarkets.com/research/q5...bal_dental
Court Sets BIOLASE Board at Four Members
Marketwire - Fri Mar 21, 2:05PM CDT
BIOLASE, Inc. (NASDAQ: BIOL) announced that on March 20, 2014, the Chancery Court of Delaware entered a status quo order establishing a Board of Directors consisting of Federico Pignatelli, Chief Executive Officer and Chairman, Frederic H. Moll, Norman J. Nemoy and James R. Talevich (the "Board"
pending outcome of the litigation filed by Oracle on March 11, 2014. During the status quo period, any Board decision requires approval of at least three of four of these directors and, in certain cases, 10 day notice prior to the decision. Concise Analysis of the International Energy Based Medical Devices Market
M2 - Fri Mar 14, 4:38AM CDT
Research and Markets (http://www.researchandmarkets.com/research/23fbb3/energy_based) has announced the addition of the "Concise Analysis of the International Energy Based Medical Devices Market" report to their offering. This report analyzes the worldwide markets for Energy Based Medical Devices in US$ Million by the following product segments: - Cryotherapy - Electrical - Radiation - Radiofrequency - Ultrasound - Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 145 companies including many key and niche players such as: - AngioDynamics, Inc. - ArthroCare Corporation - AtriCure, Inc. - BIOLASE, Inc. - biolitec AG - Biomet, Inc. - Covidien plc Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Trends, Issues & Drivers 3. Product Overview 4. Product Innovations/Introductions 5. Recent Industry Activity 6. Focus On Select Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Rest Of World IV. Competitive Landscape Total Companies Profiled: 145 (including Divisions/Subsidiaries - 180) - The United States (76) - Canada (4) - Japan (15) - Europe (54) - France (4) - Germany (20) - The United Kingdom (6) - Italy (6) - Spain (4) - Rest of Europe (14) - Asia-Pacific (Excluding Japan) (21) - Latin America (2) - Middle East (
For more information visit http://www.researchandmarkets.com/research/23...ergy_based About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. BIOLASE Comments on Oracle Partners L.P. Press Release
Marketwire - Thu Mar 13, 1:10PM CDT
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today issued a statement in response to a press release issued by Oracle Partners L.P. ("Oracle"
announcing its nomination of four director candidates to stand for election to the BIOLASE(R) Board of Directors at the Company's 2014 Annual Meeting of Stockholders. BIOLASE shareholders are not required to take any action at this time. Oracle Partners Commences Legal Action Against Biolase, Inc.
PR Newswire - Wed Mar 12, 2:19PM CDT
Oracle Partners, L.P. ("Oracle"
, Biolase, Inc.'s ("Biolase" or the "Company" (Nasdaq: BIOL) largest shareholder, announced that it has commenced legal action in the Delaware Court of Chancery against the Company seeking to enjoin action in violation of the Company's Bylaws and Delaware law. The unlawful action occurred when the Company, without approval of the Board, purportedly expanded the Company's Board of Directors from six to eight directors and reappointed two directors who had previously resigned from the Board. Specifically: Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
PR Newswire - Tue Mar 11, 12:30PM CDT
Oracle Partners, L.P. ("Oracle"
, Biolase, Inc.'s ("Biolase" or the "Company" (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board, citing management and Board entrenchment in the face of continuing poor financial performance. BIOLASE Reports 2013 Fourth Quarter, Year End Results
Marketwire - Wed Mar 05, 3:05PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today reported unaudited financial results for the fourth quarter and year ended December 31, 2013.
BIOLASE CEO to Continue at Symbolic Annual Cash Salary of $1.00
Marketwire - Wed Mar 05, 3:02PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, announced today that Chairman and Chief Executive Officer Federico Pignatelli will continue at a symbolic annual cash salary of $1.00 for the year ending December 31, 2014.
BIOLASE Declares Stock Dividend for 2014 First Quarter
Marketwire - Wed Mar 05, 3:00PM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that its Board of Directors (the "Board"
has declared a one-half percent stock dividend payable on March 28, 2014, to stockholders of record on March 14, 2014. In addition, the Board adopted a two percent annual stock dividend policy for 2014. 5 Hated Earnings Stocks You Should Love
at The Street - Tue Mar 04, 11:57AM CST
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
BIOLASE Adds Two New Independent Directors to Its Board
Marketwire - Mon Mar 03, 8:02AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that the Board of Directors (the "Board"
has appointed Paul Clark and Jeffrey Nugent to the Board. Dr. Alexander K. Arrow and Dr. Sam Low tendered their resignations from the Board on February 28, 2013. As a result of these appointments and resignations, BIOLASE's Board currently consists of six directors, five of whom are independent directors. BIOLASE(R) to Host Fourth Quarter Financial Results Conference Call on March 5, 2014
Marketwire - Wed Feb 26, 8:02AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that the Company will host a conference call on Wednesday, March 5th, at 4:30 p.m. Eastern Time to discuss its operating results for the fourth quarter and year ended December 31, 2013, and to answer questions. A press release disclosing the Company's financial results will be distributed at approximately 4:05 p.m. Eastern Standard Time that same day.
BIOLASE(R) Completes First Phase of Cost Saving Measures
Marketwire - Tue Feb 25, 8:04AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography, intra oral scanners, and chair-side milling machines and 3-D printers for dentistry, today announced that it has recently embarked on an in-depth cost saving program for fiscal 2014.
BIOLASE(R) Reaches the Mark of 25,000 Lasers Sold in Dentistry
Marketwire - Mon Feb 24, 8:03AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and GalaxyBioMill(TM) CAD/CAM systems for dentistry, today announced that it sold its 25,000th laser into the dental market last week.
BIOLASE(R) Files False Advertising Lawsuit Against Competitors
Marketwire - Fri Feb 21, 8:00AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and GalaxyBioMill(TM) CAD/CAM systems for dentistry, today announced that it filed a lawsuit in the United States District Court for the Central District of California against Fotona d.d. and Technology4Medicine L.L.C., two of its competitors (together "the Defendants"
. The lawsuit alleges six causes of action, and claims that the Defendants have made false and misleading statements regarding BIOLASE's products, technology, and management. The lawsuit, filed on February 20, 2014, seeks both cash damages and injunctive relief. Concise Analysis of the International Dental Equipment Market - Forecast to 2018
M2 - Fri Feb 21, 4:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/7s4r2f/dental_equipment) has announced the addition of the "Concise Analysis of the International Dental Equipment Market - Forecast to 2018" report to their offering. Dental Equipment and imaging devices find application in a dental office for diagnosis and treatment of various dental ailments such as caries and gingival disease. This report estimates the market of the global dental equipment market in terms of revenue (USD million) for the period 2012 - 2018, keeping 2011 as the base year. The global dental equipment market is segmented into two categories viz. market by products and market by geography. The global market by product types is further classified into six categories namely dental radiology equipment, dental lasers, systems and parts, laboratory machines, hygiene maintenance devices and other equipment. Dental radiology equipment consists of two sub-types i.e. intra-oral equipment and extra-oral equipment. The dental laser market on is further segregated the basis of technology into three types viz. diode lasers, carbon dioxide lasers and yttrium aluminum garnet lasers. Systems and parts are enumerated as instrument delivery systems, vacuums and compressors, cone beam CT systems, cast machines, furnace and ovens, electrosurgical equipment, CAD/CAM and others. The various laboratory machines described in the report are ceramic furnaces, hydraulic press, electronic waxer, suction units and micro motors. The hygiene maintenance devices include sterilizers, air purification & filters and hypodermic needle incinerators. Other equipments described in the report are dental chairs, hand piece, light cure and scaling units. The global dental equipment market is also segmented on the basis of geography into North America, Europe, Asia and Rest of the World (RoW) regions. Key Topics Covered: 1 Key Findings 2 Preface 3 Global Dental Equipment Market - Industry Analysis 4 Global Dental Equipment Market, By Products 5 Global Dental Equipment Market, By Geography 6 Company Profiles Companies Mentioned: - 3M ESPE - A- Dec Inc, - Biolase Inc. - Carestream Heath, Inc. - Danaher Corporation - Dentsply International Inc. - GC Corporation - Henry Schein, Inc. - Hu- Friedy Mgf Co. - Ivoclar Vivadent AG - Midmark Corporation - Patterson Companies Inc. - Planmecaoy - Sirona Dental Systems Inc. - Noble Biocare - Straumann For more information visit http://www.researchandmarkets.com/research/7s..._equipment
Stratasys Appoints BIOLASE(R) as a Distributor of Its Design Series 3-D Printers
Marketwire - Thu Feb 20, 8:03AM CST
BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, including the Company's proprietary WaterLase(R), and a pioneer in laser surgery in other medical specialties, as well as a distributor of digital radiography and GalaxyBioMill(TM) CAD/CAM systems for dentistry, today announced that it has entered into a Reseller Agreement (the "Agreement"
with Stratasys, Inc. (NASDAQ: SSYS). 5 Stocks Insiders Love Right Now
at The Street - Wed Feb 19, 11:49AM CST
Insiders at these companies have been scooping up shares of their own stock lately.
